EMA Authorised: Pedmarqsi (sodium thiosulfate) — Norgine B.V.

View source ↗

Summary

The European Medicines Agency has authorised Pedmarqsi, a sodium thiosulfate product by Norgine B.V., for use in ear diseases with a focus on protecting against…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ototoxicity

Drugs mentioned

• Pedmarqsi (sodium thiosulfate)

Snippet

Status: Authorised. Therapeutic area: Ear Diseases;Ototoxicity. MAH: Norgine B.V.. Decision date: 22/05/2025